Do centenarians die healthier than younger elders? A comparative epidemiological study in Spain

Clerencia-Sierra, M. ; Ioakeim-Skoufa, I. ; Poblador-Plou, B. ; Gonzalez-Rubio, F. ; Aza-Pascual-Salcedo, M. ; Machon, M. ; Gimeno-Miguel, A. ; Prados-Torres, A.

Resumen: This study aims to describe the clinical course, drug use, and health services use characteristics during the last year of life of elders who die being centenarians and to identify key aspects differentiating them from elders who die at an earlier age, with a particular focus on sex differences. We conducted an observational, population-based study in the EpiChron Cohort (Aragon, Spain). The population was stratified by sex and into three age sub-populations (80-89, 90-99, and >= 100 years), and their characteristics were described and compared. Multimorbidity was the rule in our elders, affecting up to 3 in 4 centenarians and 9 in 10 octogenarians and nonagenarians. Polypharmacy was also observed in half of the centenarian population and in most of the younger elders. Risk factors for cardiovascular disease (i.e., hypertension, dyslipidaemia, diabetes), cerebrovascular disease and dementia were amongst the most common chronic conditions in all age groups, whereas the gastroprotective drugs and antithrombotic agents were the most dispensed drugs. Centenarians presented in general lower morbidity and treatment burden and lower use of both primary and hospital healthcare services than octogenarians and nonagenarians, suggesting a better health status. Sex-differences in their clinical characteristics were more striking in octogenarians and tended to decrease with age.

Idioma: Inglés

DOI: 10.3390/jcm9051563

Año: 2020

Publicado en: JOURNAL OF CLINICAL MEDICINE 9, 5 (2020), 1563 [11 pp.]
ISSN: 2077-0383

Factor impacto JCR: 4.241 (2020)

Categ. JCR: MEDICINE, GENERAL & INTERNAL rank: 39 / 169 = 0.231 (2020) - Q1 - T1

Financiación: info:eu-repo/grantAgreement/ES/DGA-FEDER/B01-20R

Tipo y forma: Artículo (Versión definitiva)